Immunomedics - 30 Year Stock Price History | IMMU

Historical daily share price chart and data for Immunomedics since 1990 adjusted for splits. The latest closing stock price for Immunomedics as of January 27, 2020 is 18.06.
  • The all-time high Immunomedics stock closing price was 38.50 on March 06, 2000.
  • The Immunomedics 52-week high stock price is 22.22, which is 23% above the current share price.
  • The Immunomedics 52-week low stock price is 11.59, which is 35.8% below the current share price.
  • The average Immunomedics stock price for the last 52 weeks is 16.12.
Immunomedics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 19.3974 20.3600 20.3600 18.0600 18.0600 -14.65%
2019 15.8767 14.9800 21.7700 11.9800 21.1600 48.28%
2018 20.0230 15.9200 26.7600 13.9400 14.2700 -11.70%
2017 8.4777 3.7300 16.3200 3.4800 16.1600 340.33%
2016 2.8430 2.9600 5.3000 1.7200 3.6700 19.54%
2015 3.4318 4.7800 5.3500 1.5700 3.0700 -36.04%
2014 3.9806 4.9100 6.1000 3.0600 4.8000 4.35%
2013 4.0719 3.0500 7.1410 2.2400 4.6000 57.53%
2012 3.4250 3.4000 3.9100 2.8500 2.9200 -12.31%
2011 3.5976 3.5900 4.4200 2.8800 3.3300 -6.98%
2010 3.4265 3.4200 4.3400 2.8600 3.5800 11.53%
2009 2.8596 1.7600 6.8400 0.8400 3.2100 88.82%
2008 2.1840 2.2700 3.0600 1.1900 1.7000 -26.72%
2007 3.6800 3.5890 5.9400 1.9600 2.3200 -36.09%
2006 2.5661 2.7500 3.7900 1.6600 3.6300 24.32%
2005 2.2682 3.1000 3.8800 1.6300 2.9200 -3.95%
2004 3.8928 4.5400 6.2000 2.2500 3.0400 -33.33%
2003 5.5566 5.2900 9.5000 2.4000 4.5600 -1.30%
2002 10.1896 20.0100 20.9000 3.8900 4.6200 -77.20%
2001 15.7258 19.4400 24.8400 7.5630 20.2600 -5.77%
2000 20.2717 11.0000 38.5000 9.6250 21.5000 75.51%
1999 2.3448 3.6880 12.2500 1.0630 12.2500 196.97%
1998 3.9869 3.8750 6.3130 2.6250 4.1250 13.79%
1997 4.8298 5.7500 7.0000 3.3130 3.6250 -34.09%
1996 7.6001 6.0000 12.8800 5.1200 5.5000 -8.33%
1995 4.2400 3.3750 9.5000 2.2500 6.0000 71.43%
1994 4.3655 5.6250 6.3750 3.1250 3.5000 -36.36%
1993 7.3776 10.5000 12.0000 5.1250 5.5000 -50.58%
1992 9.4911 8.7500 15.8800 6.0000 11.1300 29.04%
1991 7.6077 2.8750 10.8800 2.8750 8.6250 165.38%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $3.535B $0.002B
Immunomedics Inc. is a New Jersey-based biopharmaceutical company focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases. They have developed a number of advanced proprietary technologies that allow us to create humanized antibodies that can be used either alone in unlabeled or `naked` form, or conjugated with radioactive isotopes, chemotherapeutics or toxins, in each case to create highly targeted agents. Using these technologies, the company have built a pipeline of therapeutic product candidates that utilize several different mechanisms of action. They have recently licensed its lead product candidate, epratuzumab, to UCB, S.A. for the treatment of all autoimmune disease indications worldwide.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $134.042B 15.44
CSL (CSLLY) Australia $95.565B 0.00
Gilead Sciences (GILD) United States $79.894B 9.90
Vertex Pharmaceuticals (VRTX) United States $58.903B 60.12
Biogen (BIIB) United States $50.188B 8.61
Illumina (ILMN) United States $46.978B 51.54
Regeneron Pharmaceuticals (REGN) United States $37.910B 16.60
Alexion Pharmaceuticals (ALXN) United States $23.295B 11.51
Seattle Genetics (SGEN) United States $19.464B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.134B 0.00
Incyte (INCY) United States $16.530B 38.37
BioMarin Pharmaceutical (BMRN) United States $15.475B 0.00
Genmab (GNMSF) Denmark $14.016B 61.91
Alnylam Pharmaceuticals (ALNY) United States $13.379B 0.00
Galapagos (GLPG) Belgium $12.683B 32.68
Exact Sciences (EXAS) United States $11.629B 0.00
Bio-Rad Laboratories (BIO.B) United States $11.238B 53.94
BeiGene (BGNE) Cayman Islands $9.989B 0.00
Sarepta Therapeutics (SRPT) United States $8.378B 0.00
Bio-Techne Corp (TECH) United States $8.193B 54.84
BioNTech SE (BNTX) Germany $7.917B 0.00
QIAGEN (QGEN) Netherlands $7.884B 25.71
Guardant Health (GH) United States $7.516B 0.00
Amarin (AMRN) Ireland $7.223B 0.00
Moderna (MRNA) United States $7.038B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.754B 17.17
ACADIA Pharmaceuticals (ACAD) United States $6.059B 0.00
Reata Pharmaceuticals (RETA) United States $5.857B 0.00
Ascendis Pharma (ASND) Denmark $5.722B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.516B 0.00
Exelixis (EXEL) United States $5.475B 15.40
Repligen (RGEN) United States $5.160B 93.50
Bluebird Bio (BLUE) United States $4.828B 0.00
China Biologic Products (CBPO) China $4.540B 25.58
MorphoSys AG (MOR) Germany $4.157B 0.00
Adaptive Biotechnologies (ADPT) United States $3.799B 0.00
Mirati Therapeutics (MRTX) United States $3.588B 0.00
NeoGenomics (NEO) United States $3.372B 179.44
Ultragenyx Pharmaceutical (RARE) United States $3.291B 0.00
Blueprint Medicines (BPMC) United States $3.227B 0.00
MyoKardia (MYOK) United States $3.188B 0.00
Zai Lab (ZLAB) China $3.181B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.164B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.022B 0.00
Genmab (GMAB) Denmark $2.906B 5.99
Emergent Biosolutions (EBS) United States $2.892B 28.73
Halozyme Therapeutics (HALO) United States $2.795B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.790B 0.00
Alkermes (ALKS) Ireland $2.776B 0.00
Acceleron Pharma (XLRN) United States $2.763B 0.00
UniQure (QURE) Netherlands $2.710B 0.00
Denali Therapeutics (DNLI) United States $2.367B 0.00
Amicus Therapeutics (FOLD) United States $2.278B 0.00
Arena Pharmaceuticals (ARNA) United States $2.230B 5.19
RA PHARMCTL INC (RARX) United States $2.205B 0.00
Myriad Genetics (MYGN) United States $2.129B 31.45
Epizyme (EPZM) United States $2.040B 0.00
Principia Biopharma (PRNB) United States $1.876B 0.00
Zymeworks (ZYME) Canada $1.868B 0.00
Fate Therapeutics (FATE) United States $1.826B 0.00
Insmed (INSM) United States $1.795B 0.00
Akcea Therapeutics (AKCA) United States $1.700B 0.00
Alector (ALEC) United States $1.692B 0.00
Arvinas (ARVN) United States $1.690B 0.00
REGENXBIO (RGNX) United States $1.619B 0.00
Ligand Pharmaceuticals (LGND) United States $1.555B 29.91
Editas Medicine (EDIT) United States $1.454B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.318B 0.00
Intra-Cellular Therapies (ITCI) United States $1.308B 0.00
Zealand Pharma (ZLDPF) Denmark $1.292B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.276B 0.00
Coherus BioSciences (CHRS) United States $1.273B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.270B 0.00
Zealand Pharma (ZEAL) Denmark $1.153B 0.00
Athenex (ATNX) United States $1.111B 0.00
Mesoblast (MESO) Australia $1.060B 0.00
DBV Technologies S.A (DBVT) France $1.012B 0.00
Codexis (CDXS) United States $0.988B 0.00
Revance Therapeutics (RVNC) United States $0.982B 0.00
PHARMA MAR SA (PHMMF) Spain $0.945B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.937B 0.00
Pharming Group (PHGUF) Netherlands $0.909B 0.00
Sangamo Therapeutics (SGMO) United States $0.870B 0.00
Heska (HSKA) United States $0.813B 207.72
ZIOPHARM Oncology Inc (ZIOP) United States $0.800B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.762B 6.41
Vericel (VCEL) United States $0.752B 280.33
ANI Pharmaceuticals (ANIP) United States $0.744B 12.68
Adverum Biotechnologies (ADVM) United States $0.740B 0.00
GENFIT S.A (GNFT) France $0.729B 0.00
Twist Bioscience (TWST) United States $0.720B 0.00
Sorrento Therapeutics (SRNE) United States $0.717B 0.00
Cytokineticsorporated (CYTK) United States $0.710B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.708B 0.00
Retrophin (RTRX) United States $0.701B 0.00
Cellectis S.A (CLLS) France $0.696B 0.00
Intellia Therapeutics (NTLA) United States $0.675B 0.00
Cara Therapeutics (CARA) United States $0.642B 0.00
NantKwest (NK) United States $0.642B 0.00
UROGEN PHARMA (URGN) United States $0.636B 0.00
Anika Therapeutics (ANIK) United States $0.626B 20.32
AC Immune SA (ACIU) Switzerland $0.584B 13.50
Kadmon Holdings (KDMN) United States $0.580B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.568B 0.00
Prothena (PRTA) Ireland $0.523B 0.00
Agenus (AGEN) United States $0.519B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.515B 0.00
BioDelivery Sciences (BDSI) United States $0.515B 0.00
Precision BioSciences (DTIL) United States $0.504B 0.00
Cel-Sci (CVM) United States $0.502B 0.00
Clovis Oncology (CLVS) United States $0.489B 0.00
Bellus Health (BLU) Canada $0.487B 0.00
Dynavax Technologies (DVAX) United States $0.485B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Arcus Biosciences (RCUS) United States $0.430B 0.00
Inovio Pharmaceuticals (INO) United States $0.424B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.410B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.401B 0.00
Merus (MRUS) Netherlands $0.398B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.392B 0.00
Avid Bioservices (CDMO) United States $0.389B 0.00
AnaptysBio (ANAB) United States $0.380B 0.00
Kindred Biosciences (KIN) United States $0.371B 0.00
PDL BioPharma (PDLI) United States $0.371B 9.29
MannKind (MNKD) United States $0.363B 0.00
OSMOTICA PHARM (OSMT) United States $0.361B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.357B 2.47
Mersana Therapeutics (MRSN) United States $0.355B 0.00
Pfenex (PFNX) United States $0.353B 0.00
Cue Biopharma (CUE) United States $0.350B 0.00
Gritstone Oncology (GRTS) United States $0.347B 0.00
CytomX Therapeutics (CTMX) United States $0.341B 0.00
Stemline Therapeutics (STML) United States $0.339B 0.00
Compugen (CGEN) Israel $0.339B 0.00
Cellular Biomedicine (CBMG) United States $0.330B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.327B 0.00
Puma Biotechnology (PBYI) United States $0.316B 0.00
Syros Pharmaceuticals (SYRS) United States $0.307B 0.00
Starpharma Holdings (SPHRY) Australia $0.304B 0.00
POXEL SA FRANCE (PXXLF) France $0.303B 0.00
Albireo Pharma (ALBO) United States $0.294B 0.00
IVERIC Bio (ISEE) United States $0.291B 0.00
Kamada (KMDA) Israel $0.273B 7.96
Geron (GERN) United States $0.272B 0.00
WAVE Life Sciences (WVE) Singapore $0.259B 0.00
Sutro Biopharma (STRO) United States $0.257B 0.00
ADMA Biologics Inc (ADMA) United States $0.253B 0.00
Biofrontera AG (BFRA) Germany $0.252B 0.00
Novavax (NVAX) United States $0.251B 0.00
ChromaDex (CDXC) United States $0.248B 0.00
Prometic Life Sciences (LMNL) Canada $0.245B 0.00
VBI Vaccines (VBIV) United States $0.228B 0.00
Affimed (AFMD) Germany $0.221B 0.00
Seres Therapeutics (MCRB) United States $0.219B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.214B 0.00
Theratechnologies (THTX) Canada $0.214B 0.00
Athersys (ATHX) United States $0.212B 0.00
Exicure (XCUR) United States $0.209B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.209B 0.00
Protagonist Therapeutics (PTGX) United States $0.205B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.204B 0.00
Cerecor (CERC) United States $0.203B 0.00
XOMA (XOMA) United States $0.203B 0.00
Five Prime Therapeutics (FPRX) United States $0.203B 0.00
Aptinyx (APTX) United States $0.195B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.191B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.190B 0.00
Spero Therapeutics (SPRO) United States $0.188B 0.00
Fortress Biotech (FBIO) United States $0.185B 0.00
Arbutus Biopharma (ABUS) Canada $0.180B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.178B 0.00
TELA Bio (TELA) United States $0.177B 0.00
Alcobra (ARCT) United States $0.177B 0.00
CorMedix Inc (CRMD) United States $0.175B 0.00
Strongbridge Biopharma (SBBP) United States $0.170B 4.54
Windtree Therapeutics (WINT) United States $0.161B 0.00
Palatin Technologies (PTN) United States $0.160B 4.36
ARAVIVE, INC (ARAV) United States $0.157B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.156B 8.00
PHASEBIO PHARMA (PHAS) United States $0.152B 0.00
Selecta Biosciences (SELB) United States $0.148B 0.00
Dyadic (DYAI) United States $0.142B 0.00
Verastem (VSTM) United States $0.139B 0.00
Applied Genetic Technologies (AGTC) United States $0.135B 0.00
Abeona Therapeutics (ABEO) United States $0.135B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Menlo Therapeutics (MNLO) United States $0.134B 0.00
VTv Therapeutics (VTVT) United States $0.126B 0.00
Northwest Biotherapeutics (NWBO) United States $0.124B 0.00
Enzo Biochem (ENZ) United States $0.123B 0.00
Clearside Biomedical (CLSD) United States $0.123B 0.00
Liquidia Technologies (LQDA) United States $0.122B 0.00
Aduro Biotech (ADRO) United States $0.119B 0.00
Happiness Biotech Group (HAPP) China $0.118B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.117B 0.00
Arsanis (XFOR) United States $0.116B 0.00
OvaScience (MLND) United States $0.112B 0.00
Antibe Therapeutics (ATBPF) Canada $0.110B 0.00
Celyad SA (CYAD) Belgium $0.110B 0.00
Vaccinex (VCNX) United States $0.102B 0.00
Acorda Therapeutics (ACOR) United States $0.101B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.095B 0.00
SESEN BIO, INC (SESN) United States $0.093B 0.00
AIT Therapeutics (XAIR) United States $0.091B 0.00
Trevena (TRVN) United States $0.090B 0.00
Proteostasis Therapeutics (PTI) United States $0.089B 0.00
Adocia (ADOCY) France $0.086B 0.00
Synlogic (SYBX) United States $0.086B 0.00
Catalyst Biosciences (CBIO) United States $0.081B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.080B 0.00
Orgenesis (ORGS) United States $0.079B 5.10
Prima BioMed (IMMP) Australia $0.078B 0.00
Emmaus Life Sciences (EMMA) United States $0.075B 0.00
Checkpoint Therapeutics (CKPT) United States $0.072B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.071B 0.00
NewLink Genetics (NLNK) United States $0.068B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.068B 0.00
Soligenix (SNGX) United States $0.061B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.060B 0.00
Pluristem Therapeutics (PSTI) Israel $0.060B 0.00
Curis (CRIS) United States $0.056B 0.00
Protalix BioTherapeutics (PLX) Israel $0.056B 0.00
Idera Pharmaceuticals (IDRA) United States $0.054B 0.00
Vascular Biogenics (VBLT) Israel $0.053B 0.00
DiaMedica Therapeutics (DMAC) United States $0.050B 0.00
Organovo Holdings (ONVO) United States $0.048B 0.00
AquaBounty Technologies (AQB) United States $0.048B 0.00
Evogene (EVGN) Israel $0.044B 0.00
CollPlant Holdings (CLGN) Israel $0.041B 0.00
Alimera Sciences (ALIM) United States $0.037B 0.00
Celldex Therapeutics (CLDX) United States $0.037B 0.00
Entera Bio (ENTX) Israel $0.036B 0.00
Celsion (CLSN) United States $0.035B 0.00
VistaGen Therapeutics (VTGN) United States $0.034B 0.00
BioCardia (BCDA) United States $0.034B 0.00
Unum Therapeutics (UMRX) United States $0.033B 0.00
Pulmatrix (PULM) United States $0.032B 0.00
Signal Genetics (MGEN) United States $0.031B 0.00
Bionano Genomics (BNGO) United States $0.031B 0.00
Oncobiologics (OTLK) United States $0.029B 0.00
Aptevo Therapeutics (APVO) United States $0.029B 0.00
VIVUS (VVUS) United States $0.028B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.027B 0.00
Novogen (KZIA) Australia $0.026B 0.00
AmpliPhi Biosciences (ARMP) United States $0.026B 0.00
AEterna Zentaris (AEZS) United States $0.024B 0.00
Stellar Biotechnologies (EDSA) Canada $0.023B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.021B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
Titan Pharmaceuticals (TTNP) United States $0.018B 0.00
Aytu Bioscience (AYTU) United States $0.017B 0.00
Advaxis (ADXS) United States $0.015B 0.00
Cleveland BioLabs (CBLI) United States $0.015B 0.00
Cesca Therapeutics (THMO) United States $0.014B 0.00
TOCAGEN INC (TOCA) United States $0.013B 0.00
TrovaGene (TROV) United States $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
BioPharmX (BPMX) United States $0.012B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
IBio (IBIO) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.004B 0.00